Leronlimab (anti-CCR5)

Leronlimab (anti-CCR5) (PRO 140; Vyrologix)is a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy. It is being investigated as a potential therapy in the treatment of HIV infection.
Supplier Selleck Chemicals
Product # A2040
Sku # A2040-1mg*5
Pricing 1mg*5, $1077.00
Feedback